| Non-Small Cell Lung Cancer |
1 |
1 |
| Lung Cancer |
0 |
0.9 |
| Biologic Therapy |
0 |
0.99 |
| Targeted Cancer Therapy |
0 |
0.76 |
| Small Cell Lung Cancer |
0 |
0.53 |
| Genomic Medicine |
0 |
0.48 |
| Cancer |
0 |
0.45 |
| Quality of Life |
0 |
0.98 |
| Anaplastic Lymphoma Kinase |
0 |
0.43 |
| ALK Inhibitor |
0 |
0.38 |
| Chemotherapy |
0 |
0.3 |
| Epidermal Growth Factor Receptor |
0 |
0.3 |
| Immunotherapy |
0 |
0.3 |
| Lung |
0 |
0.3 |
| Europe |
0 |
0.15 |
| Lymphoma |
0 |
0.15 |
| Receptors |
0 |
0.15 |
| Surgery |
0 |
0.15 |
| Texas |
0 |
0.15 |